SAN DIEGO, CALIFORNIA / ACCESSWIRE / December 23, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or "Company"), a clinical-stage pharmaceutical company developing innovative solutions for s ...
Alnylam Canada ULC is pleased to announce that GIVLAARI® (givosiran injection) is now funded across Canada through both public and private insurance plans for patients living with acute hepatic ...
REFINE data showed patients with resistant and refractory migraine have a higher burden of comorbidities than those with nonresistant and nonrefractory migraine.